This article considers the challenges and potential benefits of combining the two. The nasal delivery of biologics offers considerable potential for both local and systemic action and for direct access to the brain and CNS to address currently unmet therapeutic need. The unique features of biologics are discussed with reference to the associated difficulties of nasal delivery and the benefits of partnership with experts such as Aptar Pharma is highlighted. Work on the development of vaccines and prophylactics for COVID-19 illustrates what is achievable.
Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery
This Might Also Be of Interest
Investigation of Powder Blend Uniformity and Deposition in a Nasal Cast Using a Unit ...
Publications, Pharmaceutical, Product Solutions, Device Innovations
In Vitro and In Vivo Assessment of Regional Nasal Deposition using Scintigraphy from ...
Publications, Pharmaceutical, Device Innovations, Product Solutions
Nasal Drug Delivery: Beyond Hayfever
Webinars, Pharmaceutical, Innovation & Insights, Market Insights, Product Solutions
Digital Health and Digital Therapeutics: Where are we heading and why?
Webinars, Pharmaceutical, Market Insights, Product Solutions, Device Innovations, Brand Differentiation
